NYSE:EW - Edwards Lifesciences Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $100.50
  • Forecasted Upside: -4.07 %
  • Number of Analysts: 17
  • Breakdown:
  • 1 Sell Ratings
  • 4 Hold Ratings
  • 12 Buy Ratings
  • 0 Strong Buy Ratings
$104.76
▲ +0.24 (0.23%)

This chart shows the closing price for EW by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Edwards Lifesciences Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EW and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EW

Analyst Price Target is $100.50
▼ -4.07% Downside Potential
This price target is based on 17 analysts offering 12 month price targets for Edwards Lifesciences in the last 3 months. The average price target is $100.50, with a high forecast of $111.00 and a low forecast of $85.00. The average price target represents a -4.07% upside from the last price of $104.76.

This chart shows the closing price for EW for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 17 contributing investment analysts is to buy stock in Edwards Lifesciences. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 13 buy ratings
  • 5 hold ratings
  • 0 sell ratings
12/31/2019
  • 0 strong buy ratings
  • 16 buy ratings
  • 6 hold ratings
  • 0 sell ratings
3/30/2020
  • 0 strong buy ratings
  • 17 buy ratings
  • 6 hold ratings
  • 0 sell ratings
6/28/2020
  • 0 strong buy ratings
  • 15 buy ratings
  • 5 hold ratings
  • 1 sell ratings
9/26/2020
  • 0 strong buy ratings
  • 13 buy ratings
  • 7 hold ratings
  • 1 sell ratings
12/25/2020
  • 0 strong buy ratings
  • 13 buy ratings
  • 5 hold ratings
  • 1 sell ratings
3/25/2021
  • 0 strong buy ratings
  • 12 buy ratings
  • 4 hold ratings
  • 1 sell ratings
5/24/2021
  • 0 strong buy ratings
  • 12 buy ratings
  • 4 hold ratings
  • 1 sell ratings
6/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 12 buy ratings
  • 4 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/24/2021BarclaysInitiated CoverageOverweight$110.00Low
4/21/2021Morgan StanleyBoost Price TargetOverweight$99.00 ➝ $108.00High
4/21/2021Raymond JamesBoost Price TargetOutperform$96.00 ➝ $101.00High
4/21/2021Wells Fargo & CompanyBoost Price TargetEqual Weight$87.00 ➝ $93.00High
4/21/2021Canaccord GenuityBoost Price TargetBuy$94.00 ➝ $103.00High
4/21/2021Piper SandlerBoost Price TargetOverweight$97.00 ➝ $105.00High
4/15/2021Atlantic SecuritiesInitiated CoverageNeutral$85.00Low
4/5/2021Evercore ISIUpgradeIn-Line ➝ OutperformMedium
12/16/2020Smith Barney CitigroupDowngradeBuy ➝ NeutralLow
12/16/2020Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellDowngradeBuy ➝ Neutral$97.00Low
12/14/2020Morgan StanleyBoost Price TargetOverweight$88.00 ➝ $99.00Medium
12/11/2020Raymond JamesBoost Price TargetOutperform$90.00 ➝ $96.00Low
12/11/2020Canaccord GenuityBoost Price TargetBuy$89.00 ➝ $94.00High
12/11/2020Piper SandlerBoost Price TargetOverweight$93.00 ➝ $98.00High
12/11/2020SVB LeerinkBoost Price TargetOutperform$100.00 ➝ $106.00High
12/7/2020Credit Suisse GroupBoost Price Target$97.00 ➝ $111.00Medium
11/18/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$84.00 ➝ $87.00Low
10/27/2020Jefferies Financial GroupBoost Price TargetBuy$95.00 ➝ $105.00Medium
10/22/2020Credit Suisse GroupBoost Price TargetOutperform$92.00 ➝ $97.00High
10/22/2020Raymond JamesBoost Price TargetOutperform$88.00 ➝ $90.00High
10/19/2020CowenBoost Price TargetOutperform$85.00 ➝ $100.00Medium
10/14/2020Piper SandlerBoost Price TargetOverweight$91.00 ➝ $93.00Low
10/12/2020SVB LeerinkBoost Price TargetOutperform$95.00 ➝ $100.00Low
9/11/2020Wolfe ResearchInitiated CoverageUnderperformLow
7/24/2020Stifel NicolausBoost Price TargetBuy$85.00 ➝ $90.00Low
7/24/2020Canaccord GenuityBoost Price TargetBuy$86.00 ➝ $89.00Medium
7/24/2020Jefferies Financial GroupBoost Price TargetBuy$87.00 ➝ $95.00Low
7/24/2020Credit Suisse GroupBoost Price TargetOutperform$88.00 ➝ $92.00High
7/24/2020Morgan StanleyBoost Price TargetOverweight$83.00 ➝ $88.00High
7/24/2020SVB LeerinkBoost Price TargetOutperform$90.00 ➝ $95.00High
7/24/2020Raymond JamesBoost Price TargetOutperform$83.00 ➝ $88.00High
7/24/2020Piper SandlerBoost Price TargetPositive ➝ Overweight$88.00 ➝ $91.00High
7/13/2020OppenheimerInitiated CoverageBuy$93.00High
6/29/2020Morgan StanleyLower Price TargetOverweight$83.33 ➝ $83.00Low
6/2/2020Credit Suisse GroupLower Price TargetOutperform$88.00High
6/1/2020Morgan StanleyLower Price TargetOverweight$83.33 ➝ $83.00N/A
4/28/2020Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$83.33 ➝ $76.67High
4/27/2020BarclaysReiterated RatingUnderweight$55.00 ➝ $51.67High
4/24/2020CfraBoost Price TargetBuy$67.00 ➝ $77.00Low
4/24/2020Raymond JamesBoost Price TargetOutperform$76.67 ➝ $83.33Low
4/24/2020Stifel NicolausBoost Price TargetBuy$76.67 ➝ $85.00Low
4/24/2020Piper SandlerLower Price TargetOverweight$90.00 ➝ $88.33Low
4/24/2020Morgan StanleyBoost Price TargetOverweight$80.33 ➝ $83.33High
4/24/2020Credit Suisse GroupBoost Price TargetOutperform$86.67 ➝ $87.33High
4/24/2020Wells Fargo & CompanyBoost Price TargetOverweight$71.67 ➝ $83.33High
4/24/2020Canaccord GenuityReiterated RatingBuyHigh
4/24/2020CitigroupBoost Price TargetBuy$80.00 ➝ $85.00High
4/23/2020BTIG ResearchReiterated RatingHoldHigh
4/22/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$81.67 ➝ $75.00Low
4/20/2020CowenLower Price TargetTop Pick ➝ Outperform$91.67 ➝ $83.33Medium
4/19/2020SVB LeerinkDowngradeOutperform ➝ Market PerformMedium
4/17/2020SVB LeerinkUpgradeMarket Perform ➝ Outperform$90.00High
4/9/2020Raymond JamesLower Price TargetOutperform$87.67 ➝ $76.67High
4/6/2020Wells Fargo & CompanyLower Price TargetOverweight$90.67 ➝ $71.67Low
3/27/2020Morgan StanleyLower Price TargetOverweight$90.00 ➝ $80.33Low
3/27/2020CitigroupLower Price TargetBuy$84.00 ➝ $80.00Low
3/13/2020CfraUpgradeSell ➝ Hold$69.00 ➝ $67.00High
3/6/2020Credit Suisse GroupLower Price TargetOutperform$92.67 ➝ $89.00Low
3/4/2020CitigroupInitiated CoverageBuy$84.00Low
2/25/2020Canaccord GenuityReiterated RatingBuyLow
2/12/2020The Goldman Sachs GroupInitiated CoverageNeutral$84.33Low
2/6/2020BTIG ResearchInitiated CoverageHoldMedium
1/31/2020CfraBoost Price TargetSell$68.33 ➝ $69.00High
1/31/2020Stifel NicolausBoost Price TargetBuy$91.67 ➝ $93.33High
1/31/2020Wells Fargo & CompanyBoost Price TargetOverweight$90.00 ➝ $90.67High
1/31/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$78.67 ➝ $81.67High
1/31/2020Credit Suisse GroupBoost Price TargetOutperform$91.67 ➝ $92.67High
1/31/2020Piper SandlerBoost Price TargetOverweight$87.33 ➝ $90.00High
1/31/2020UBS GroupBoost Price TargetNeutral$85.00 ➝ $86.67High
1/31/2020Canaccord GenuityReiterated RatingBuy$100.00High
1/9/2020OppenheimerUpgradeMarket Perform ➝ Buy$93.33Medium
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageHold$54.67Low
12/17/2019CowenReiterated RatingBuy$91.67Medium
12/9/2019Piper Jaffray CompaniesBoost Price TargetOverweight$85.00 ➝ $87.33High
12/6/2019Canaccord GenuityReiterated RatingBuy$86.67Low
12/6/2019UBS GroupBoost Price TargetNeutral$83.33 ➝ $85.00High
12/6/2019Wells Fargo & CompanyBoost Price TargetOutperform$87.33 ➝ $90.00High
12/6/2019Credit Suisse GroupBoost Price TargetOutperform$89.67 ➝ $91.67High
12/6/2019Morgan StanleyBoost Price TargetOverweight$82.67 ➝ $90.00High
12/6/2019Raymond JamesBoost Price TargetOutperform$85.00 ➝ $87.67High
12/3/2019Jefferies Financial GroupBoost Price TargetBuy$85.00 ➝ $95.00Low
10/24/2019Canaccord GenuityBoost Price TargetBuy$83.33 ➝ $86.67High
10/24/2019Raymond JamesBoost Price TargetOutperform$83.33 ➝ $85.00High
10/24/2019CowenBoost Price TargetOutperform ➝ Positive$83.33 ➝ $88.33High
10/24/2019Wells Fargo & CompanyBoost Price TargetOutperform$83.33 ➝ $87.33High
10/24/2019Piper Jaffray CompaniesBoost Price TargetOverweight$80.00 ➝ $85.00High
10/22/2019Royal Bank of CanadaBoost Price TargetBuy ➝ Outperform$72.33 ➝ $83.33Medium
10/16/2019UBS GroupBoost Price TargetNeutral$68.33 ➝ $76.67Low
10/14/2019Raymond JamesBoost Price TargetOutperform$77.33 ➝ $83.33Low
10/14/2019Credit Suisse GroupBoost Price TargetPositive ➝ Outperform$75.33 ➝ $87.00Low
9/23/2019Piper Jaffray CompaniesInitiated CoverageOverweight$80.00 ➝ $80.00Low
9/6/2019Wells Fargo & CompanyBoost Price TargetOutperform$73.33 ➝ $83.33Low
7/26/2019CitigroupSet Price TargetSell$53.00Low
7/25/2019BTIG ResearchReiterated RatingHoldLow
7/24/2019BMO Capital MarketsBoost Price TargetOutperform$68.00 ➝ $74.67Low
7/24/2019JPMorgan Chase & Co.Boost Price TargetNeutral$63.33 ➝ $75.00Low
7/24/2019Bank of AmericaReiterated RatingBuy ➝ Buy$71.67 ➝ $75.00Low
7/24/2019Wells Fargo & CompanyBoost Price TargetOutperform$69.00 ➝ $73.33High
7/24/2019Morgan StanleyBoost Price TargetOverweight$70.00 ➝ $76.00High
7/24/2019Raymond JamesBoost Price TargetOutperform$66.67 ➝ $77.33High
7/24/2019BarclaysBoost Price TargetUnderweight$53.33 ➝ $58.33High
7/24/2019Credit Suisse GroupBoost Price TargetOutperform$73.67 ➝ $75.33High
7/24/2019Jefferies Financial GroupBoost Price TargetBuy$70.00 ➝ $81.67High
7/24/2019Canaccord GenuityBoost Price TargetBuy$71.67 ➝ $83.33High
7/16/2019Morgan StanleyBoost Price TargetOverweight$65.67 ➝ $70.00Medium
4/24/2019Stifel NicolausBoost Price TargetBuy ➝ Buy$63.33 ➝ $66.67Low
4/24/2019Deutsche Bank AktiengesellschaftBoost Price TargetHold ➝ Hold$54.67 ➝ $61.33Low
4/24/2019Jefferies Financial GroupBoost Price TargetBuy$65.00 ➝ $70.00Low
4/24/2019Raymond JamesLower Price TargetOutperform ➝ Outperform$70.00 ➝ $66.67Low
4/24/2019BTIG ResearchReiterated RatingHoldLow
4/15/2019Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$63.00 ➝ $73.67Low
3/27/2019JPMorgan Chase & Co.Boost Price TargetNeutral$58.33 ➝ $63.33Low
3/25/2019BarclaysBoost Price TargetUnderweight$50.00 ➝ $53.33Low
3/22/2019BMO Capital MarketsBoost Price TargetOutperform$68.00Low
3/18/2019Morgan StanleyBoost Price TargetOverweight ➝ Overweight$60.00 ➝ $65.67High
3/18/2019Wells Fargo & CompanyBoost Price TargetOutperform$62.67 ➝ $67.33High
3/18/2019Bank of AmericaBoost Price TargetBuy ➝ Buy$63.33 ➝ $71.67Medium
3/18/2019Canaccord GenuityReiterated RatingBuy ➝ Buy$63.33 ➝ $71.67High
3/12/2019UBS GroupBoost Price TargetNeutral ➝ Neutral$58.33 ➝ $60.00Medium
2/25/2019CitigroupBoost Price TargetSell ➝ Sell$39.67 ➝ $43.33Medium
2/4/2019CowenReiterated RatingBuyMedium
2/3/2019Stifel NicolausReiterated RatingBuy$63.33Medium
1/18/2019Bank of AmericaUpgradeNeutral ➝ Buy$60.00 ➝ $63.33High
1/16/2019Canaccord GenuityBoost Price TargetBuy ➝ Positive$59.00 ➝ $62.00High
1/2/2019Deutsche Bank AktiengesellschaftInitiated CoverageHold ➝ Hold$54.67High
1/2/2019CitigroupBoost Price TargetSell ➝ Sell$39.33 ➝ $39.67Low
12/17/2018Credit Suisse GroupInitiated CoverageOutperform$62.67Low
12/10/2018CowenSet Price TargetBuy$63.33Low
12/7/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$52.33 ➝ $60.00Medium
12/6/2018Stifel NicolausReiterated RatingPositiveHigh
12/6/2018Raymond JamesBoost Price TargetOutperform ➝ Outperform$53.33 ➝ $58.33High
12/6/2018Royal Bank of CanadaBoost Price TargetOutperform$58.33High
12/6/2018Jefferies Financial GroupBoost Price TargetPositive ➝ Buy$56.00 ➝ $60.00High
11/30/2018CowenSet Price TargetBuy$63.33Low
11/27/2018UBS GroupInitiated CoverageNeutral ➝ Neutral$55.00 ➝ $55.00High
10/29/2018CitigroupLower Price TargetSell ➝ Sell$40.33 ➝ $39.33High
10/24/2018BarclaysSet Price TargetSell$47.67High
10/15/2018BarclaysInitiated CoverageUnderweight ➝ Underweight$47.67High
10/11/2018Morgan StanleyBoost Price TargetOverweight$50.00 ➝ $52.33Medium
10/11/2018Northland SecuritiesReiterated RatingHold$40.00Medium
10/2/2018Bank of AmericaDowngradeBuy ➝ NeutralMedium
10/2/2018GuggenheimDowngradeBuy ➝ NeutralHigh
9/28/2018SunTrust BanksBoost Price TargetBuy$66.67Medium
8/10/2018SunTrust BanksLower Price TargetBuy$56.67Low
7/31/2018CitigroupBoost Price TargetSell ➝ Sell$38.33 ➝ $39.33Low
7/27/2018GuggenheimReiterated RatingBuy$56.67Low
7/27/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$46.00 ➝ $50.00Medium
7/27/2018Wells Fargo & CompanyBoost Price TargetOutperform ➝ Outperform$50.67 ➝ $56.67Medium
7/27/2018JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$44.33 ➝ $50.00High
7/27/2018Jefferies Financial GroupReiterated RatingBuy$56.00High
7/27/2018Northland SecuritiesReiterated RatingHold$40.00High
7/10/2018BMO Capital MarketsBoost Price TargetOutperform$54.00Low
6/27/2018Sanford C. BernsteinInitiated CoverageMarket Perform$55.00High
5/31/2018Raymond JamesInitiated CoverageOutperform$50.67Low
5/23/2018Royal Bank of CanadaBoost Price TargetOutperform$48.33High
4/25/2018Royal Bank of CanadaReiterated RatingOutperform$46.67Low
4/25/2018Northland SecuritiesDowngradeOutperform ➝ Market PerformHigh
4/10/2018SunTrust BanksReiterated RatingBuy$60.00Medium
3/20/2018CowenReiterated RatingBuy$55.00Low
2/2/2018GuggenheimReiterated RatingBuy$54.00Low
2/2/2018JMP SecuritiesBoost Price TargetMarket Outperform ➝ Market Outperform$45.00 ➝ $46.67High
2/2/2018Stifel NicolausReiterated RatingBuy$51.67High
2/2/2018BarclaysBoost Price TargetOverweight ➝ Overweight$45.00 ➝ $51.67High
2/2/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$43.33 ➝ $46.00High
2/2/2018Canaccord GenuityReiterated RatingBuy ➝ Buy$46.67 ➝ $58.00High
2/1/2018CowenReiterated RatingBuy$50.00High
1/31/2018SunTrust BanksReiterated RatingBuy$50.00Low
1/4/2018BarclaysUpgradeEqual Weight ➝ Overweight$41.67 ➝ $45.00Low
1/3/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$46.67High
1/2/2018JPMorgan Chase & Co.DowngradeOverweight ➝ NeutralMedium
12/10/2017CowenSet Price TargetBuy$45.00Low
12/8/2017BMO Capital MarketsReiterated RatingBuy$45.67Low
11/29/2017Canaccord GenuityReiterated RatingBuy$45.67Low
10/26/2017Deutsche Bank AktiengesellschaftLower Price TargetHold$40.67 ➝ $38.33N/A
10/26/2017Morgan StanleyLower Price TargetOverweight$44.33 ➝ $40.00N/A
10/25/2017BarclaysLower Price TargetEqual Weight$40.00 ➝ $39.33N/A
10/25/2017SunTrust BanksSet Price TargetBuy$41.33N/A
10/25/2017Canaccord GenuityReiterated RatingBuy$51.67 ➝ $45.00N/A
10/12/2017CowenReiterated RatingBuy$45.00N/A
10/8/2017Canaccord GenuityReiterated RatingBuy$51.67N/A
9/30/2017BarclaysReiterated RatingEqual Weight$40.00Low
9/1/2017Royal Bank of CanadaReiterated RatingBuy$43.33N/A
9/1/2017BMO Capital MarketsReiterated RatingBuy$44.00N/A
8/28/2017William BlairReiterated RatingOutperform ➝ OutperformLow
7/30/2017Canaccord GenuityReiterated RatingBuy$50.00 ➝ $51.67Low
7/28/2017Royal Bank of CanadaReiterated RatingBuy$43.33Low
7/27/2017CowenReiterated RatingOutperform$43.33 ➝ $45.00Low
7/27/2017BarclaysBoost Price TargetEqual Weight$36.00 ➝ $40.00Low
7/27/2017Stifel NicolausReiterated RatingBuy ➝ Buy$39.33 ➝ $43.33High
7/27/2017Bank of AmericaBoost Price TargetPositive ➝ Buy$46.67 ➝ $50.00High
7/27/2017Jefferies Financial GroupBoost Price TargetBuy$38.33 ➝ $44.00High
7/17/2017SunTrust BanksBoost Price TargetBuy$4.67Low
6/30/2017Jefferies Financial GroupReiterated RatingBuy$38.33Low
6/28/2017Canaccord GenuityReiterated RatingBuy$50.00Low
5/30/2017Royal Bank of CanadaReiterated RatingBuyLow
5/30/2017Bank of AmericaBoost Price TargetBuy$40.00 ➝ $46.67Low
5/27/2017Jefferies Financial GroupSet Price TargetBuy$38.33N/A
5/16/2017The Goldman Sachs GroupInitiated CoverageConviction-Buy$46.00Low
4/26/2017Jefferies Financial GroupReiterated RatingBuyLow
4/26/2017Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$38.67 ➝ $40.00High
4/26/2017Stifel NicolausBoost Price TargetBuy ➝ Buy$38.00 ➝ $39.33High
3/28/2017CowenReiterated RatingOutperform$40.00Medium
3/27/2017Evercore ISIUpgradeIn-Line ➝ Outperform$32.83 ➝ $36.67Low
3/20/2017Northland SecuritiesSet Price TargetBuy$35.00Low
3/11/2017Northland SecuritiesReiterated RatingOutperform$35.00N/A
2/27/2017Northland SecuritiesReiterated RatingOutperform$35.00N/A
2/21/2017Northland SecuritiesReiterated RatingPositive$35.00N/A
2/8/2017Credit Suisse GroupSet Price TargetBuy$40.00N/A
2/5/2017Deutsche Bank AktiengesellschaftReiterated RatingHold$33.33N/A
2/2/2017Canaccord GenuitySet Price TargetBuy$46.67N/A
2/2/2017Northland SecuritiesReiterated RatingPositive$35.00N/A
2/2/2017SVB LeerinkDowngradeOutperform ➝ Market PerformN/A
2/2/2017BTIG ResearchDowngradeBuy ➝ NeutralN/A
1/3/2017GuggenheimUpgradeNeutral ➝ Buy$40.00N/A
12/10/2016JMP SecuritiesReiterated RatingEqual Weight$43.33N/A
12/10/2016BarclaysReiterated RatingEqual Weight$33.33N/A
12/10/2016BTIG ResearchReiterated RatingBuy$36.67N/A
12/9/2016Jefferies Financial GroupReiterated RatingBuy$38.33N/A
12/9/2016Canaccord GenuityReiterated RatingBuy$46.67N/A
12/7/2016CowenReiterated RatingOutperform ➝ Buy$43.33 ➝ $40.00N/A
12/1/2016JPMorgan Chase & Co.Set Price TargetBuy$40.00N/A
11/29/2016Northland SecuritiesReiterated RatingOutperform$35.00N/A
11/28/2016Canaccord GenuitySet Price TargetBuy$46.67N/A
11/28/2016Evercore ISIReiterated RatingHold$35.00N/A
11/22/2016Canaccord GenuitySet Price TargetBuy$46.67N/A
11/8/2016Northland SecuritiesUpgradeMarket Perform ➝ Outperform$35.00N/A
10/28/2016SVB LeerinkReiterated RatingOutperform$43.33N/A
10/28/2016BTIG ResearchReiterated RatingBuy$36.67N/A
10/26/2016Royal Bank of CanadaReiterated RatingOutperform$43.33 ➝ $41.00N/A
10/26/2016Jefferies Financial GroupReiterated RatingBuy$41.67 ➝ $38.33N/A
10/26/2016Stifel NicolausLower Price TargetBuy$40.67 ➝ $38.00N/A
10/26/2016Royal Bank of CanadaLower Price TargetOutperform$43.33 ➝ $41.00N/A
9/11/2016Wells Fargo & CompanyReiterated RatingBuyN/A
8/22/2016UBS GroupReiterated RatingBuyN/A
8/19/2016SVB LeerinkReiterated RatingBuyN/A
8/19/2016Morgan StanleyReiterated RatingBuy$46.67N/A
8/19/2016Evercore ISIReiterated RatingHold$38.33N/A
8/18/2016Credit Suisse GroupSet Price TargetBuy$38.67N/A
8/18/2016Canaccord GenuityReiterated RatingBuy$46.67N/A
7/28/2016JPMorgan Chase & Co.Reiterated RatingBuy$43.33N/A
7/28/2016JMP SecuritiesBoost Price TargetMarket Outperform$41.67 ➝ $43.33N/A
7/27/2016CitigroupBoost Price TargetSell$28.67 ➝ $31.33N/A
7/27/2016BarclaysBoost Price TargetEqual Weight$35.00 ➝ $38.33N/A
7/27/2016BMO Capital MarketsReiterated RatingBuy$40.00N/A
7/27/2016Deutsche Bank AktiengesellschaftBoost Price TargetHold$33.33 ➝ $38.33N/A
7/27/2016Jefferies Financial GroupReiterated RatingBuy$41.67N/A
7/27/2016Canaccord GenuityBoost Price TargetBuy$44.00 ➝ $46.67N/A
7/27/2016SVB LeerinkBoost Price TargetOutperform$41.67 ➝ $43.33N/A
7/27/2016BTIG ResearchBoost Price TargetBuy$40.67 ➝ $43.33N/A
7/27/2016UBS GroupReiterated RatingBuy$45.00 ➝ $46.33N/A
7/27/2016Bank of AmericaUpgradeNeutral ➝ Buy$43.33N/A
7/27/2016Morgan StanleyBoost Price TargetOverweight$36.67 ➝ $46.67N/A
7/12/2016JPMorgan Chase & Co.Reiterated RatingBuyN/A
(Data available from 6/24/2016 forward)
Edwards Lifesciences logo
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Read More

Today's Range

Now: $104.76
Low: $104.25
High: $105.10

50 Day Range

MA: $95.00
Low: $87.47
High: $104.76

52 Week Range

Now: $104.76
Low: $66.45
High: $105.10

Volume

2,068,741 shs

Average Volume

2,626,453 shs

Market Capitalization

$65.12 billion

P/E Ratio

77.60

Dividend Yield

N/A

Beta

1.09

Frequently Asked Questions

What sell-side analysts currently cover shares of Edwards Lifesciences?

The following equities research analysts have issued reports on Edwards Lifesciences in the last twelve months: Atlantic Securities, Barclays PLC, Canaccord Genuity, Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Cowen Inc, Credit Suisse Group AG, Evercore ISI, Jefferies Financial Group Inc., Morgan Stanley, Oppenheimer Holdings Inc., Piper Sandler, Raymond James, Smith Barney Citigroup, Stifel Nicolaus, SVB Leerink LLC, Wells Fargo & Company, Wolfe Research, and Zacks Investment Research.
View the latest analyst ratings for EW.

What is the current price target for Edwards Lifesciences?

14 Wall Street analysts have set twelve-month price targets for Edwards Lifesciences in the last year. Their average twelve-month price target is $100.50, suggesting a possible downside of 4.1%. Credit Suisse Group AG has the highest price target set, predicting EW will reach $111.00 in the next twelve months. Atlantic Securities has the lowest price target set, forecasting a price of $85.00 for Edwards Lifesciences in the next year.
View the latest price targets for EW.

What is the current consensus analyst rating for Edwards Lifesciences?

Edwards Lifesciences currently has 1 sell rating, 4 hold ratings and 12 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe EW will outperform the market and that investors should add to their positions of Edwards Lifesciences.
View the latest ratings for EW.

What other companies compete with Edwards Lifesciences?

How do I contact Edwards Lifesciences' investor relations team?

Edwards Lifesciences' physical mailing address is ONE EDWARDS WAY, IRVINE CA, 92614. The medical research company's listed phone number is 949-250-2500 and its investor relations email address is [email protected] The official website for Edwards Lifesciences is www.edwards.com.